Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,4.4446018419517467e-44,37.78512668641,3771.788948974021,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.8667327736197337e-41,0,0,73
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.5862199357142847e-29,20.965082444228905,1390.2703827982687,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",3.331061864999998e-27,0,0,55
3,Oxidative phosphorylation WP623,2.8822943863843394e-18,21.135938135938137,853.6371076968517,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'ATP6AP2', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",4.035212140938075e-16,0,0,33
4,Nonalcoholic fatty liver disease WP4396,2.552128650332825e-15,6.245201834342977,209.8503266334828,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'UQCRFS1', 'CYC1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'EIF2S1', 'COX6B1', 'NDUFS8', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'CYCS', 'BAX', 'PPARA']",2.679735082849466e-13,0,0,47
5,Mitochondrial complex I assembly model OXPHOS system WP4324,1.9283750330278987e-10,10.208278457196613,228.35074922446117,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'DMAC1', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3']",1.619835027743435e-08,0,0,23
6,Mitochondrial CIV Assembly WP4922,8.690195871105699e-08,9.382600561272216,152.54687297377308,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'COX6B1', 'COX14', 'SMIM20', 'COX20']",6.083137109773989e-06,0,0,17
7,Mitochondrial complex III assembly WP4921,0.00035009189855716744,8.764378478664193,69.74091920018637,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.021005513913430047,0,0,8
8,Synaptic Vesicle Pathway WP2267,0.005334539973490283,3.3707463540177294,17.64097843255026,"['UNC13B', 'UNC13C', 'SLC32A1', 'CLTC', 'AP2S1', 'PARK7', 'SYP', 'SLC25A4', 'AP2M1', 'CPLX3']",0.2800633486082399,0,0,10
9,Proteasome Degradation WP183,0.011792187180730619,2.677519379844961,11.889037685437176,"['PSMB6', 'PSMC5', 'PSMB5', 'UBB', 'H2AFZ', 'PSMC4', 'PSMC1', 'RPN1', 'HLA-B', 'UBA1', 'PSMB10']",0.42586982066784007,0,0,11
10,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.01236298530183326,3.8276181649675625,16.814911575399098,"['RPTOR', 'DEPTOR', 'MAP1LC3A', 'WIPI1', 'ATG7', 'COASY', 'FTL']",0.42586982066784007,0,0,7
11,Parkinson's disease pathway WP2371,0.01236298530183326,3.8276181649675625,16.814911575399098,"['UBB', 'CASP6', 'CCNE1', 'CYCS', 'UBA1', 'PARK7', 'UBE2J1']",0.42586982066784007,0,0,7
12,Cellular Proteostasis WP4918,0.013181684925433146,8.735674676524955,37.81609725860832,"['VBP1', 'PFDN4', 'PFDN5', 'PFDN6']",0.42586982066784007,0,0,4
13,Glycolysis in senescence WP5049,0.013181684925433146,8.735674676524955,37.81609725860832,"['LDHA', 'PKM', 'ALDOC', 'GAPDH']",0.42586982066784007,0,0,4
14,Ferroptosis WP4313,0.021709289767657586,2.9165120593692024,11.170284964674192,"['MAP1LC3A', 'GPX4', 'FTH1', 'GSS', 'SLC3A2', 'SAT2', 'ATG7', 'FTL']",0.5873328783346563,0,0,8
15,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.022374585841320238,13.094182825484765,49.75566250442295,"['GSTP1', 'EPHX2', 'COX5A']",0.5873328783346563,0,0,3
16,Glutathione metabolism WP100,0.022374585841320238,13.094182825484765,49.75566250442295,"['GPX4', 'IDH1', 'GSS']",0.5873328783346563,0,0,3
17,Nanomaterial induced apoptosis WP2507,0.026241758849777825,5.822550831792976,21.19643319153825,"['ENDOG', 'CASP6', 'BAX', 'CYCS']",0.6123077064948159,0,0,4
18,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.026241758849777825,5.822550831792976,21.19643319153825,"['EIF3I', 'EIF2S1', 'EIF3D', 'EIF1']",0.6123077064948159,0,0,4
19,Base Excision Repair WP4752,0.036543929822636115,2.781952986772264,9.206150617450465,"['POLE4', 'PCNA', 'NEIL2', 'MPG', 'TDG', 'APEX1', 'POLD2']",0.8078131855530089,0,0,7
20,Hippo-Yap signaling pathway WP4537,0.04483839040040307,4.365988909426987,13.555044630464261,"['MAP4K2', 'NF2', 'TNIK', 'STK3']",0.9094236344996237,0,0,4
21,Pyrimidine metabolism WP4022,0.047122323947402206,1.9453755431409063,5.9431386664748596,"['POLE4', 'POLR3GL', 'POLR1B', 'POLD2', 'NME2', 'ENPP1', 'NME3', 'POLR2I', 'DCTPP1', 'POLR2K', 'NME1', 'POLR2L']",0.9094236344996237,0,0,12
22,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.048201558618620924,6.545706371191136,19.84896384375997,"['MAP1LC3A', 'WIPI1', 'ATG7']",0.9094236344996237,0,0,3
23,Amino Acid metabolism WP3925,0.04980177046069368,2.0831120552310143,6.2487211147015165,"['LARS2', 'LDHA', 'PKM', 'GOT1', 'MDH2', 'RARS', 'IDH1', 'GSS', 'ODC1', 'SRM']",0.9094236344996237,0,0,10
24,Apoptosis Modulation by HSP70 WP384,0.09158813545158423,8.72140221402214,20.848106807863363,"['CASP6', 'CYCS']",0.9992262839210598,0,0,2
25,Cytosine methylation WP3585,0.09158813545158423,8.72140221402214,20.848106807863363,"['IDH1', 'TDG']",0.9992262839210598,0,0,2
26,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.09158813545158423,8.72140221402214,20.848106807863363,"['EPHX2', 'PPARA']",0.9992262839210598,0,0,2
27,Translation Factors WP107,0.09592068401275719,1.9418676561533705,4.552191478570416,"['EEF1B2', 'EIF2B5', 'EIF2AK1', 'EIF3I', 'EIF2B1', 'EIF2S1', 'EIF3D', 'EIF1']",0.9992262839210598,0,0,8
28,7q11.23 copy number variation syndrome WP4932,0.09796004744912332,1.624524031420583,3.774087021012914,"['PCNA', 'CLTC', 'ATP5MC2', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5PO', 'SQSTM1', 'GAPDH', 'VPS28', 'CLASP1']",0.9992262839210598,0,0,13
29,Oxidative Damage WP3941,0.09859372000430129,2.909426987060998,6.740408312717077,"['PCNA', 'BAD', 'TRAF3', 'CYCS']",0.9992262839210598,0,0,4
30,Glycolysis and Gluconeogenesis WP534,0.09970856507417447,2.038368860055607,4.699466943191214,"['LDHA', 'PKM', 'GOT1', 'MDH2', 'PGAM1', 'ALDOC', 'GAPDH']",0.9992262839210598,0,0,7
31,CAMKK2  Pathway WP4874,0.10285524819598277,2.425223558433549,5.516007612143493,"['RPTOR', 'FIS1', 'MAP1LC3A', 'SQSTM1', 'CALM2']",0.9992262839210598,0,0,5
32,Histone Modifications WP2369,0.10285524819598277,2.425223558433549,5.516007612143493,"['SET', 'SETDB1', 'H3F3B', 'SETDB2', 'KMT5A']",0.9992262839210598,0,0,5
33,Cori Cycle WP1946,0.1259562877095687,3.2714681440443214,6.777894292095974,"['LDHA', 'PGAM1', 'GAPDH']",0.9992262839210598,0,0,3
34,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.1259562877095687,3.2714681440443214,6.777894292095974,"['FGF1', 'GTPBP4', 'FGFR2']",0.9992262839210598,0,0,3
35,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.1259562877095687,3.2714681440443214,6.777894292095974,"['GOT1', 'MDH2', 'NAMPT']",0.9992262839210598,0,0,3
36,Urea cycle and metabolism of amino groups WP497,0.1259562877095687,3.2714681440443214,6.777894292095974,"['ODC1', 'CKB', 'SRM']",0.9992262839210598,0,0,3
37,Zinc homeostasis WP3529,0.1259562877095687,3.2714681440443214,6.777894292095974,"['SLC30A3', 'SLC39A11', 'SLC39A7']",0.9992262839210598,0,0,3
38,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.1329333425168715,2.4932664378135727,5.031180945825357,"['NDUFA13', 'HSP90AA1', 'RIPK2', 'AAMP']",0.9992262839210598,0,0,4
39,SARS-CoV-2 mitochondrial interactions WP5038,0.1329333425168715,2.4932664378135727,5.031180945825357,"['TOMM70', 'NDUFB9', 'IRF3', 'TRAF3']",0.9992262839210598,0,0,4
40,Acetylcholine Synthesis WP528,0.16080172476082205,4.3597785977859775,7.96785810433648,"['ACHE', 'CHKA']",0.9992262839210598,0,0,2
41,Dual hijack model of Vif in HIV infection WP3300,0.16080172476082205,4.3597785977859775,7.96785810433648,"['UBB', 'ELOB']",0.9992262839210598,0,0,2
42,Transcription co-factors SKI and SKIL protein partners WP4533,0.16080172476082205,4.3597785977859775,7.96785810433648,"['MERTK', 'STK3']",0.9992262839210598,0,0,2
43,16p11.2 distal deletion syndrome WP4950,0.1746270432048868,2.6166204986149584,4.566271656476685,"['RAB4A', 'CD81', 'SPNS1']",0.9992262839210598,0,0,3
44,Computational Model of Aerobic Glycolysis WP4629,0.1746270432048868,2.6166204986149584,4.566271656476685,"['LDHA', 'PKM', 'GAPDH']",0.9992262839210598,0,0,3
45,DNA Mismatch Repair WP531,0.1746270432048868,2.6166204986149584,4.566271656476685,"['POLE4', 'PCNA', 'POLD2']",0.9992262839210598,0,0,3
46,Melatonin metabolism and effects WP3298,0.1746270432048868,2.6166204986149584,4.566271656476685,"['ACHE', 'APOE', 'CALM2']",0.9992262839210598,0,0,3
47,miRNA regulation of p53 pathway in prostate cancer WP3982,0.1746270432048868,2.6166204986149584,4.566271656476685,"['SESN3', 'SHISA5', 'BAX']",0.9992262839210598,0,0,3
48,Nucleotide metabolism WP404,0.1746270432048868,2.6166204986149584,4.566271656476685,"['NME2', 'OAZ1', 'SRM']",0.9992262839210598,0,0,3
49,Serotonin and anxiety WP3947,0.1746270432048868,2.6166204986149584,4.566271656476685,"['FMR1', 'CRH', 'HTR2C']",0.9992262839210598,0,0,3
50,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.18679025496373877,inf,inf,['TRAF3'],0.9992262839210598,0,0,1
51,EV release from cardiac cells and their functional effects WP3297,0.18679025496373877,inf,inf,['RGS16'],0.9992262839210598,0,0,1
52,Nanomaterial-induced inflammasome activation WP3890,0.18679025496373877,inf,inf,['CTSB'],0.9992262839210598,0,0,1
53,Nanoparticle triggered regulated necrosis WP2513,0.18679025496373877,inf,inf,['FTL'],0.9992262839210598,0,0,1
54,Valproic acid pathway WP3871,0.18679025496373877,inf,inf,['IVD'],0.9992262839210598,0,0,1
55,Alzheimer's disease WP2059,0.20936563338946326,1.518109219972574,2.3738265705574615,"['ATP5MD', 'APH1A', 'BAD', 'CHP1', 'CYCS', 'APOE', 'GAPDH', 'CALM2']",0.9992262839210598,0,0,8
56,Differentiation Pathway WP2848,0.2130125829901406,1.9383857054836722,2.997527485934483,"['LEFTY1', 'WNT2B', 'KIT', 'FGF1']",0.9992262839210598,0,0,4
57,Selenium Micronutrient Network WP15,0.21569694230614173,1.636111111111111,2.509599585846087,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'SELENOK', 'SELENOH']",0.9992262839210598,0,0,6
58,Autophagy WP4923,0.22741657855988112,2.1800554016620497,3.228600562459187,"['RPTOR', 'DEPTOR', 'ATG7']",0.9992262839210598,0,0,3
59,Gastric Cancer Network 2 WP2363,0.22741657855988112,2.1800554016620497,3.228600562459187,"['OTUD5', 'S100A6', 'BRIX1']",0.9992262839210598,0,0,3
60,Hematopoietic Stem Cell Differentiation WP2849,0.22741657855988112,2.1800554016620497,3.228600562459187,"['SEC14L2', 'PIM1', 'ACVR1B']",0.9992262839210598,0,0,3
61,Cytosolic DNA-sensing pathway WP4655,0.23500112814388263,1.6775777414075286,2.429409309890614,"['CYLD', 'IRF3', 'POLR3GL', 'POLR2K', 'POLR2L']",0.9992262839210598,0,0,5
62,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.23500112814388263,1.6775777414075286,2.429409309890614,"['OTUD5', 'CYLD', 'IRF3', 'TRAF3', 'PIN1']",0.9992262839210598,0,0,5
63,Regulatory circuits of the STAT3 signaling pathway WP4538,0.23500112814388263,1.6775777414075286,2.429409309890614,"['RPTOR', 'DEPTOR', 'TRIM28', 'IFNGR2', 'STMN1']",0.9992262839210598,0,0,5
64,Cysteine and methionine catabolism WP4504,0.2358685136110425,2.9059040590405902,4.197522547092025,"['GOT1', 'GSS']",0.9992262839210598,0,0,2
65,Kennedy pathway from sphingolipids WP3933,0.2358685136110425,2.9059040590405902,4.197522547092025,"['CHKA', 'ETNK1']",0.9992262839210598,0,0,2
66,Nanoparticle triggered autophagic cell death WP2509,0.2358685136110425,2.9059040590405902,4.197522547092025,"['MAP1LC3A', 'ATG7']",0.9992262839210598,0,0,2
67,Wnt signaling in kidney disease WP4150,0.2358685136110425,2.9059040590405902,4.197522547092025,"['WNT2B', 'DVL3']",0.9992262839210598,0,0,2
68,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.24900072880103377,1.5395424836601308,2.1404250769210402,"['PPP1R14A', 'PPP1R3F', 'MAP1LC3A', 'EIF2AK1', 'DDIT3', 'EIF2S1']",0.9992262839210598,0,0,6
69,Metabolic reprogramming in colon cancer WP4290,0.24900072880103377,1.5395424836601308,2.1404250769210402,"['LDHA', 'PKM', 'MDH2', 'PGAM1', 'GAPDH', 'IDH3A']",0.9992262839210598,0,0,6
70,Amyotrophic lateral sclerosis (ALS) WP2447,0.2570755171418595,1.744177449168207,2.3692651753852254,"['GRIA1', 'TOMM40', 'BAD', 'BAX']",0.9992262839210598,0,0,4
71,NO/cGMP/PKG mediated Neuroprotection WP4008,0.2570755171418595,1.744177449168207,2.3692651753852254,"['BAD', 'PDE3A', 'CYCS', 'CALM2']",0.9992262839210598,0,0,4
72,DNA Repair Pathways Full Network WP4946,0.2731986240408829,1.3222372423115918,1.715677115437231,"['POLE4', 'DCLRE1C', 'NEIL2', 'PCNA', 'CENPX', 'MPG', 'TDG', 'APEX1', 'POLD2', 'GTF2H5']",0.9992262839210598,0,0,10
73,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.28262637274509045,1.8682231895528294,2.3607419185940435,"['H3F3B', 'BCL6', 'H2AFZ']",0.9992262839210598,0,0,3
74,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.28262637274509045,1.8682231895528294,2.3607419185940435,"['MAP4K2', 'NF2', 'STK3']",0.9992262839210598,0,0,3
75,PKC-gamma calcium signaling pathway in ataxia WP4760,0.28262637274509045,1.8682231895528294,2.3607419185940435,"['PRKCG', 'GRIA1', 'TRPC3']",0.9992262839210598,0,0,3
76,Apoptosis WP254,0.2836192512114957,1.4537037037037037,1.8318448981025965,"['IRF3', 'CASP6', 'TRAF3', 'BAD', 'CYCS', 'BAX']",0.9992262839210598,0,0,6
77,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.31219202590070805,2.178966789667897,2.5366154538620234,"['ENPP1', 'FGFR2']",0.9992262839210598,0,0,2
78,HIF1A and PPARG regulation of glycolysis WP2456,0.31219202590070805,2.178966789667897,2.5366154538620234,"['LDHA', 'GAPDH']",0.9992262839210598,0,0,2
79,Mitochondrial Gene Expression WP391,0.31219202590070805,2.178966789667897,2.5366154538620234,"['PPRC1', 'PPARGC1B']",0.9992262839210598,0,0,2
80,SARS coronavirus and innate immunity WP4912,0.31219202590070805,2.178966789667897,2.5366154538620234,"['IRF3', 'TRAF3']",0.9992262839210598,0,0,2
81,Serotonin and anxiety-related events WP3944,0.31219202590070805,2.178966789667897,2.5366154538620234,"['CRH', 'HTR2C']",0.9992262839210598,0,0,2
82,IL-18 signaling pathway WP4754,0.31818825645237553,1.1775580204017997,1.3484359022204158,"['TOMM40', 'USP5', 'PHF20', 'CD81', 'BAD', 'RGS16', 'COX17', 'NDUFC1', 'RND2', 'RPTOR', 'LARS2', 'NACA', 'TMSB4X', 'STMN1', 'CYCS', 'BAX', 'AARS']",0.9992262839210598,0,0,17
83,Fragile X Syndrome  WP4549,0.3251990313575472,1.2302683363148479,1.3819824192797425,"['GRIA1', 'RPTOR', 'DEPTOR', 'DUSP3', 'ALDH5A1', 'FMR1', 'CLTC', 'AP2S1', 'AKAP5', 'DLGAP3', 'AP2M1']",0.9992262839210598,0,0,11
84,15q11.2 copy number variation syndrome WP4940,0.3387160565100016,4.35668202764977,4.716513962991999,['FMR1'],0.9992262839210598,0,0,1
85,Composition of Lipid Particles WP3601,0.3387160565100016,4.35668202764977,4.716513962991999,['APOE'],0.9992262839210598,0,0,1
86,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.3387160565100016,4.35668202764977,4.716513962991999,['VIP'],0.9992262839210598,0,0,1
87,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.3387160565100016,4.35668202764977,4.716513962991999,['GSS'],0.9992262839210598,0,0,1
88,Gastric acid production WP2596,0.3387160565100016,4.35668202764977,4.716513962991999,['VIP'],0.9992262839210598,0,0,1
89,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.3387160565100016,4.35668202764977,4.716513962991999,['ELOB'],0.9992262839210598,0,0,1
90,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.3387160565100016,4.35668202764977,4.716513962991999,['BLVRB'],0.9992262839210598,0,0,1
91,Irinotecan pathway WP229,0.3387160565100016,4.35668202764977,4.716513962991999,['CES2'],0.9992262839210598,0,0,1
92,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.3387160565100016,4.35668202764977,4.716513962991999,['BAX'],0.9992262839210598,0,0,1
93,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.3387160565100016,4.35668202764977,4.716513962991999,['APOE'],0.9992262839210598,0,0,1
94,NAD+ metabolism WP3644,0.3387160565100016,4.35668202764977,4.716513962991999,['NAMPT'],0.9992262839210598,0,0,1
95,Peroxiredoxin 2 induced ovarian failure WP4873,0.3387160565100016,4.35668202764977,4.716513962991999,['BAX'],0.9992262839210598,0,0,1
96,"Phase I biotransformations, non P450 WP136",0.3387160565100016,4.35668202764977,4.716513962991999,['CES2'],0.9992262839210598,0,0,1
97,Fas ligand pathway and stress induction of heat shock proteins WP314,0.3387612491284769,1.634349030470914,1.7691169605328192,"['CASP6', 'RIPK2', 'CYCS']",0.9992262839210598,0,0,3
98,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.3387612491284769,1.634349030470914,1.7691169605328192,"['MDH2', 'IDH3G', 'IDH3A']",0.9992262839210598,0,0,3
99,White fat cell differentiation WP4149,0.3387612491284769,1.634349030470914,1.7691169605328192,"['IRF3', 'DDIT3', 'NR2F2']",0.9992262839210598,0,0,3
100,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.3490770713950163,1.4528650646950092,1.5290860652992408,"['RPTOR', 'DEPTOR', 'MAP1LC3A', 'IGFBP5']",0.9992262839210598,0,0,4
101,GABA receptor Signaling WP4159,0.3490770713950163,1.4528650646950092,1.5290860652992408,"['GABBR1', 'SLC32A1', 'AP2S1', 'AP2M1']",0.9992262839210598,0,0,4
102,One-carbon metabolism and related pathways WP3940,0.3490770713950163,1.4528650646950092,1.5290860652992408,"['GPX4', 'CHKA', 'GSS', 'ETNK1']",0.9992262839210598,0,0,4
103,Wnt Signaling Pathway WP363,0.3490770713950163,1.4528650646950092,1.5290860652992408,"['PRKCG', 'DVL3', 'ARRB2', 'ROR2']",0.9992262839210598,0,0,4
104,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.3535838408498892,1.3621646623496761,1.4161535795552769,"['BEX3', 'RIPK2', 'RNF7', 'APOE', 'SQSTM1']",0.9992262839210598,0,0,5
105,Proximal tubule transport WP4917,0.3535838408498892,1.3621646623496761,1.4161535795552769,"['ATP6V1A', 'ATP6V1G1', 'SLC13A3', 'SLC3A2', 'ATP6V1F']",0.9992262839210598,0,0,5
106,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.3866863000361925,1.7428044280442805,1.6559108289503524,"['BAD', 'BAX']",0.9992262839210598,0,0,2
107,Immune response to tuberculosis WP4197,0.3866863000361925,1.7428044280442805,1.6559108289503524,"['IFNGR2', 'PTPN2']",0.9992262839210598,0,0,2
108,NAD+ biosynthetic pathways WP3645,0.3866863000361925,1.7428044280442805,1.6559108289503524,"['NAPRT', 'NAMPT']",0.9992262839210598,0,0,2
109,Prostaglandin Synthesis and Regulation WP98,0.3866863000361925,1.7428044280442805,1.6559108289503524,"['S100A6', 'PPARGC1B']",0.9992262839210598,0,0,2
110,Tryptophan catabolism leading to NAD+ production WP4210,0.3866863000361925,1.7428044280442805,1.6559108289503524,"['NAPRT', 'NAMPT']",0.9992262839210598,0,0,2
111,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.3866863000361925,1.7428044280442805,1.6559108289503524,"['IRF3', 'TRAF3']",0.9992262839210598,0,0,2
112,Type II diabetes mellitus WP1584,0.3866863000361925,1.7428044280442805,1.6559108289503524,"['SURF1', 'PHKA2']",0.9992262839210598,0,0,2
113,DNA IR-double strand breaks and cellular response via ATM WP3959,0.39413879968085047,1.2817652500408119,1.1933902896251458,"['DCLRE1C', 'PCNA', 'TRIM28', 'BAX', 'STK3']",0.9992262839210598,0,0,5
114,Development of ureteric collection system WP5053,0.39551082411436234,1.3408218398976255,1.2437156660097748,"['ROBO2', 'GDF11', 'FAT4', 'FGFR2']",0.9992262839210598,0,0,4
115,mRNA Processing WP411,0.3980804970462864,1.137235851348069,1.0475091257012181,"['LSM7', 'SF3A1', 'CELF1', 'HNRNPA2B1', 'SNRPG', 'SNRPB2', 'SNRPF', 'DNAJC8', 'HNRNPA1', 'SRSF7', 'PRPF8', 'SRSF9']",0.9992262839210598,0,0,12
116,VEGFA-VEGFR2 Signaling Pathway WP3888,0.40381181172139197,1.0662234884457107,0.9668582001113353,"['YWHAE', 'RPL5', 'SET', 'CLTC', 'ARRB2', 'RPL10A', 'RPL7', 'SCUBE2', 'LDHA', 'RPL18A', 'TMSB4X', 'AP2S1', 'RPLP2', 'DNAJB9', 'WASF1', 'CCT7', 'RAB4A', 'HSP90AA1', 'TRPC3', 'RPS6', 'SARS', 'RPL13A', 'PDIA6', 'INPP4B', 'RCN1', 'PTPN9', 'CYCS', 'RPL27', 'RPL26', 'ATP6V0D1', 'GAPDH', 'EIF3D', 'PTMA']",0.9992262839210598,0,0,33
117,Ebola Virus Pathway on Host WP4217,0.4169077981490937,1.162152133580705,1.0167555000129,"['IRF3', 'CLTC', 'VPS4A', 'HLA-B', 'DAB2IP', 'MERTK', 'EIF2S1', 'CTSB']",0.9992262839210598,0,0,8
118,Apoptosis Modulation and Signaling WP1772,0.42814753218394186,1.1883838383838383,1.0080910857015952,"['ENDOG', 'CASP6', 'TRAF3', 'BAD', 'CYCS', 'BAX']",0.9992262839210598,0,0,6
119,Ectoderm Differentiation WP2858,0.4284761485313777,1.1148729042725798,0.9448773125981527,"['GRAMD1B', 'GREB1', 'ARHGDIG', 'PIM1', 'DMD', 'ROR2', 'NR2F2', 'NF2', 'MZF1', 'CELSR2', 'FGFR2']",0.9992262839210598,0,0,11
120,Eukaryotic Transcription Initiation WP405,0.4344549164077897,1.2102991057662658,1.0089817036729956,"['TAF13', 'POLR1B', 'TAF6', 'POLR2I', 'POLR2K']",0.9992262839210598,0,0,5
121,NRF2 pathway WP2884,0.4408109112802839,1.1204934341424593,0.9178401715449153,"['HSP90AA1', 'FTH1', 'GSTP1', 'SLC39A11', 'BLVRB', 'SLC39A7', 'SQSTM1', 'CES2', 'FTL']",0.9992262839210598,0,0,9
122,Modulators of TCR signaling and T cell activation WP5072,0.4413707202358742,1.2447847900712965,1.0180722871433032,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7']",0.9992262839210598,0,0,4
123,Metapathway biotransformation Phase I and II WP702,0.4477842167235105,1.1244239631336406,0.9034114861527981,"['CYP4Z1', 'CYP4X1', 'GPX4', 'GSTO1', 'EPHX2', 'GSTP1', 'GSS', 'KCNAB3']",0.9992262839210598,0,0,8
124,Pathways in clear cell renal cell carcinoma WP4018,0.4477842167235105,1.1244239631336406,0.9034114861527981,"['RPTOR', 'TOX2', 'LDHA', 'DEPTOR', 'PKM', 'ALDOC', 'GAPDH', 'SQSTM1']",0.9992262839210598,0,0,8
125,Complement system WP2806,0.4490322061711048,1.3069252077562328,1.046403606138314,"['RPS19', 'CD59', 'ARRB2']",0.9992262839210598,0,0,3
126,DNA Replication WP466,0.4490322061711048,1.3069252077562328,1.046403606138314,"['PCNA', 'POLD2', 'UBA52']",0.9992262839210598,0,0,3
127,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.4490322061711048,1.3069252077562328,1.046403606138314,"['RAB4A', 'RAB4B', 'RABAC1']",0.9992262839210598,0,0,3
128,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.4490322061711048,1.3069252077562328,1.046403606138314,"['HSP90AA1', 'CCNE1', 'BAX']",0.9992262839210598,0,0,3
129,Airway smooth muscle cell contraction WP4962,0.45737268865822484,1.452029520295203,1.1358598341339667,"['PPP1R14A', 'CALM2']",0.9992262839210598,0,0,2
130,Cell migration and invasion through p75NTR WP4561,0.45737268865822484,1.452029520295203,1.1358598341339667,"['EFNA3', 'CDH11']",0.9992262839210598,0,0,2
131,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.45737268865822484,1.452029520295203,1.1358598341339667,"['CD63', 'CD81']",0.9992262839210598,0,0,2
132,Hedgehog Signaling Pathway WP4249,0.45737268865822484,1.452029520295203,1.1358598341339667,"['ARRB2', 'KIF7']",0.9992262839210598,0,0,2
133,MTHFR deficiency WP4288,0.45737268865822484,1.452029520295203,1.1358598341339667,"['CHKA', 'CYCS']",0.9992262839210598,0,0,2
134,Pregnane X receptor pathway WP2876,0.45737268865822484,1.452029520295203,1.1358598341339667,"['HSP90AA1', 'PSMC5']",0.9992262839210598,0,0,2
135,Type II interferon signaling (IFNG) WP619,0.45737268865822484,1.452029520295203,1.1358598341339667,"['IFNGR2', 'HLA-B']",0.9992262839210598,0,0,2
136,Urea cycle and associated pathways WP4595,0.45737268865822484,1.452029520295203,1.1358598341339667,"['GOT1', 'MDH2']",0.9992262839210598,0,0,2
137,Ciliary landscape WP4352,0.46130905625076124,1.0582119470800482,0.8187248865860138,"['NDUFA5', 'SSNA1', 'VPS4A', 'COPS7A', 'MYL6B', 'WDR34', 'COX6C', 'LSM4', 'SPATA7', 'MYL6', 'MFAP1', 'PSMC4', 'TNKS1BP1', 'DVL3', 'SNRPB2', 'DCAF11', 'CALM2']",0.9992262839210598,0,0,17
138,15q13.3 copy number variation syndrome WP4942,0.4622799448313036,2.1778801843317974,1.680418876680964,['OTUD7A'],0.9992262839210598,0,0,1
139,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.4622799448313036,2.1778801843317974,1.680418876680964,['APOE'],0.9992262839210598,0,0,1
140,Caloric restriction and aging WP4191,0.4622799448313036,2.1778801843317974,1.680418876680964,['NAMPT'],0.9992262839210598,0,0,1
141,Cell Differentiation - Index WP2029,0.4622799448313036,2.1778801843317974,1.680418876680964,['LEFTY1'],0.9992262839210598,0,0,1
142,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.4622799448313036,2.1778801843317974,1.680418876680964,['PPARA'],0.9992262839210598,0,0,1
143,Hedgehog Signaling Pathway Netpath WP47,0.4622799448313036,2.1778801843317974,1.680418876680964,['KIF7'],0.9992262839210598,0,0,1
144,Homologous recombination WP186,0.4622799448313036,2.1778801843317974,1.680418876680964,['POLD2'],0.9992262839210598,0,0,1
145,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.4622799448313036,2.1778801843317974,1.680418876680964,['VEGFB'],0.9992262839210598,0,0,1
146,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.4622799448313036,2.1778801843317974,1.680418876680964,['ECI1'],0.9992262839210598,0,0,1
147,Non-homologous end joining WP438,0.4622799448313036,2.1778801843317974,1.680418876680964,['DCLRE1C'],0.9992262839210598,0,0,1
148,Osteoclast Signaling WP12,0.4622799448313036,2.1778801843317974,1.680418876680964,['ATP6V1G1'],0.9992262839210598,0,0,1
149,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.4622799448313036,2.1778801843317974,1.680418876680964,['FURIN'],0.9992262839210598,0,0,1
150,SARS-CoV-2 and COVID-19 Pathway WP4846,0.4622799448313036,2.1778801843317974,1.680418876680964,['FURIN'],0.9992262839210598,0,0,1
151,Trans-sulfuration pathway WP2333,0.4622799448313036,2.1778801843317974,1.680418876680964,['GOT1'],0.9992262839210598,0,0,1
152,Acute viral myocarditis WP4298,0.47414849593282143,1.1463557135206193,0.8554504392454082,"['ENDOG', 'CASP6', 'CYCS', 'BAX', 'DMD']",0.9992262839210598,0,0,5
153,Regulation of Microtubule Cytoskeleton WP2038,0.4861292181681938,1.1615526802218115,0.8378056573711289,"['PARD6A', 'STMN1', 'MAPRE1', 'CLASP1']",0.9992262839210598,0,0,4
154,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.49953289038970056,1.0888888888888888,0.7557779996739885,"['PRKCG', 'BAD', 'RPS6', 'PDGFC', 'BAX', 'FGFR2']",0.9992262839210598,0,0,6
155,MECP2 and Associated Rett Syndrome WP3584,0.49953289038970056,1.0888888888888888,0.7557779996739885,"['GRIA1', 'RBFOX1', 'BCL6', 'SST', 'RPS6', 'MBP']",0.9992262839210598,0,0,6
156,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.5128877829876607,1.0888066604995374,0.7269942521027407,"['RPTOR', 'PFKFB2', 'BAD', 'RPS6', 'ZNF516']",0.9992262839210598,0,0,5
157,GDNF/RET signaling axis WP4830,0.5230743974530114,1.2443331576172905,0.8063671743251147,"['ROBO2', 'FAT4']",0.9992262839210598,0,0,2
158,Globo Sphingolipid Metabolism WP1424,0.5230743974530114,1.2443331576172905,0.8063671743251147,"['ST6GAL1', 'ST6GAL2']",0.9992262839210598,0,0,2
159,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5230743974530114,1.2443331576172905,0.8063671743251147,"['B4GALT2', 'B3GALT2']",0.9992262839210598,0,0,2
160,Monoamine Transport WP727,0.5230743974530114,1.2443331576172905,0.8063671743251147,"['UNC13B', 'ACHE']",0.9992262839210598,0,0,2
161,Neural Crest Cell Migration during Development WP4564,0.5230743974530114,1.2443331576172905,0.8063671743251147,"['CDH11', 'EPHB3']",0.9992262839210598,0,0,2
162,Neural Crest Cell Migration in Cancer WP4565,0.5230743974530114,1.2443331576172905,0.8063671743251147,"['CDH11', 'EPHB3']",0.9992262839210598,0,0,2
163,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.5230743974530114,1.2443331576172905,0.8063671743251147,"['OMG', 'MBP']",0.9992262839210598,0,0,2
164,Toll-like Receptor Signaling related to MyD88 WP3858,0.5230743974530114,1.2443331576172905,0.8063671743251147,"['IRF3', 'TRAF3']",0.9992262839210598,0,0,2
165,Nucleotide Excision Repair WP4753,0.5293560196682074,1.088724584103512,0.6925312501199129,"['POLE4', 'PCNA', 'POLD2', 'GTF2H5']",0.9992262839210598,0,0,4
166,Copper homeostasis WP3286,0.5510565306919958,1.0886426592797784,0.6487416240221416,"['COX17', 'COMMD1', 'ATOX1']",0.9992262839210598,0,0,3
167,Energy Metabolism WP1541,0.5510565306919958,1.0886426592797784,0.6487416240221416,"['PPRC1', 'PPARA', 'PPARGC1B']",0.9992262839210598,0,0,3
168,Glycogen Synthesis and Degradation WP500,0.5510565306919958,1.0886426592797784,0.6487416240221416,"['PHKG1', 'PHKA2', 'CALM2']",0.9992262839210598,0,0,3
169,Regulation of toll-like receptor signaling pathway WP1449,0.5517453920335419,1.0159406858202038,0.6041480105153432,"['OTUD5', 'CYLD', 'CUEDC2', 'IRF3', 'TRAF3', 'SQSTM1', 'RNF41']",0.9992262839210598,0,0,7
170,ACE Inhibitor Pathway WP554,0.5627726121511507,1.4516129032258065,0.8345026719888121,['ATP6AP2'],0.9992262839210598,0,0,1
171,Aspirin and miRNAs WP4707,0.5627726121511507,1.4516129032258065,0.8345026719888121,['PPARA'],0.9992262839210598,0,0,1
172,Autosomal recessive Osteopetrosis pathways WP4788,0.5627726121511507,1.4516129032258065,0.8345026719888121,['OSTM1'],0.9992262839210598,0,0,1
173,Biogenic Amine Synthesis WP550,0.5627726121511507,1.4516129032258065,0.8345026719888121,['ACHE'],0.9992262839210598,0,0,1
174,Biomarkers for urea cycle disorders WP4583,0.5627726121511507,1.4516129032258065,0.8345026719888121,['GOT1'],0.9992262839210598,0,0,1
175,Estrogen Receptor Pathway WP2881,0.5627726121511507,1.4516129032258065,0.8345026719888121,['PPARA'],0.9992262839210598,0,0,1
176,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.5627726121511507,1.4516129032258065,0.8345026719888121,['GABBR1'],0.9992262839210598,0,0,1
177,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.5627726121511507,1.4516129032258065,0.8345026719888121,['SQSTM1'],0.9992262839210598,0,0,1
178,Mammalian disorder of sexual development WP4842,0.5627726121511507,1.4516129032258065,0.8345026719888121,['FGFR2'],0.9992262839210598,0,0,1
179,Mitochondrial fatty acid synthesis pathway WP4317,0.5627726121511507,1.4516129032258065,0.8345026719888121,['HSD17B12'],0.9992262839210598,0,0,1
180,Selective expression of chemokine receptors during T-cell polarization WP4494,0.5627726121511507,1.4516129032258065,0.8345026719888121,['IFNGR2'],0.9992262839210598,0,0,1
181,TCA cycle in senescence WP5050,0.5627726121511507,1.4516129032258065,0.8345026719888121,['GOT1'],0.9992262839210598,0,0,1
182,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.570714153875006,1.024464499293248,0.5745881262974698,"['BAD', 'STMN1', 'BAX', 'ANGPTL1']",0.9992262839210598,0,0,4
183,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.5831863618679337,1.088560885608856,0.5870048068286513,"['IFITM3', 'DDIT3']",0.9992262839210598,0,0,2
184,Imatinib and Chronic Myeloid Leukemia WP3640,0.5831863618679337,1.088560885608856,0.5870048068286513,"['KIT', 'PIM1']",0.9992262839210598,0,0,2
185,Oxidation by Cytochrome P450 WP43,0.5831863618679337,1.088560885608856,0.5870048068286513,"['CYP4Z1', 'CYP4X1']",0.9992262839210598,0,0,2
186,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.5831863618679337,1.088560885608856,0.5870048068286513,"['RPTOR', 'BAD']",0.9992262839210598,0,0,2
187,TLR4 Signaling and Tolerance WP3851,0.5831863618679337,1.088560885608856,0.5870048068286513,"['IRF3', 'TRAF3']",0.9992262839210598,0,0,2
188,TP53 network WP1742,0.5831863618679337,1.088560885608856,0.5870048068286513,"['SUMO1', 'BAX']",0.9992262839210598,0,0,2
189,Retinoblastoma gene in cancer WP2446,0.5864413689928809,0.9894037507358506,0.5280275498195481,"['PCNA', 'H2AFZ', 'CCNE1', 'STMN1', 'SAP30']",0.9992262839210598,0,0,5
190,TNF-alpha signaling pathway WP231,0.5864413689928809,0.9894037507358506,0.5280275498195481,"['MAP4K2', 'HSP90AA1', 'BAD', 'BAX', 'KSR2']",0.9992262839210598,0,0,5
191,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.5976671424230756,1.0046878329426805,0.5171342254796063,"['LDHA', 'PKM', 'BAX']",0.9992262839210598,0,0,3
192,Photodynamic therapy-induced unfolded protein response WP3613,0.5976671424230756,1.0046878329426805,0.5171342254796063,"['DDIT3', 'DNAJB9', 'PDIA6']",0.9992262839210598,0,0,3
193,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.5998162353270182,0.967283950617284,0.4944097271745195,"['PSMC5', 'CCNE1', 'PSMC4', 'PSMC1', 'UBA1', 'UBE2J1']",0.9992262839210598,0,0,6
194,Endometrial cancer WP4155,0.6099530937468045,0.9673444239063462,0.4782291779552918,"['BAD', 'BAX', 'FGF1', 'FGFR2']",0.9992262839210598,0,0,4
195,Neural Crest Differentiation WP2064,0.6099530937468045,0.9673444239063462,0.4782291779552918,"['LHX2', 'DVL3', 'MBP', 'FGFR2']",0.9992262839210598,0,0,4
196,Fatty acid beta-oxidation WP143,0.6375030082084067,0.9674046740467405,0.43552198860847585,"['ECI1', 'CPT1B']",0.9992262839210598,0,0,2
197,Fluoropyrimidine Activity WP1601,0.6375030082084067,0.9674046740467405,0.43552198860847585,"['TDG', 'CES2']",0.9992262839210598,0,0,2
198,Glycosylation and related congenital defects WP4521,0.6375030082084067,0.9674046740467405,0.43552198860847585,"['DPM2', 'MAGT1']",0.9992262839210598,0,0,2
199,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.6375030082084067,0.9674046740467405,0.43552198860847585,"['LDHA', 'RPS6']",0.9992262839210598,0,0,2
200,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.6375030082084067,0.9674046740467405,0.43552198860847585,"['IRF3', 'TRAF3']",0.9992262839210598,0,0,2
201,Methionine De Novo and Salvage Pathway WP3580,0.6375030082084067,0.9674046740467405,0.43552198860847585,"['ODC1', 'SRM']",0.9992262839210598,0,0,2
202,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.6375030082084067,0.9674046740467405,0.43552198860847585,"['IDH1', 'IDH3A']",0.9992262839210598,0,0,2
203,Common Pathways Underlying Drug Addiction WP2636,0.6409863182301768,0.9327265532251682,0.41482749185644674,"['GRIA1', 'PRKCG', 'CALM2']",0.9992262839210598,0,0,3
204,Biomarkers for pyrimidine metabolism disorders WP4584,0.6444985630652528,1.088479262672811,0.4781500943140669,['CKB'],0.9992262839210598,0,0,1
205,"Cerebral organic acidurias, including diseases WP4519",0.6444985630652528,1.088479262672811,0.4781500943140669,['MDH2'],0.9992262839210598,0,0,1
206,Complement and Coagulation Cascades WP558,0.6444985630652528,1.088479262672811,0.4781500943140669,['CLTC'],0.9992262839210598,0,0,1
207,Disorders of the Krebs cycle WP4236,0.6444985630652528,1.088479262672811,0.4781500943140669,['DHTKD1'],0.9992262839210598,0,0,1
208,Glial Cell Differentiation WP2276,0.6444985630652528,1.088479262672811,0.4781500943140669,['MBP'],0.9992262839210598,0,0,1
209,Heart Development WP1591,0.6444985630652528,1.088479262672811,0.4781500943140669,['VEGFB'],0.9992262839210598,0,0,1
210,ID signaling pathway WP53,0.6444985630652528,1.088479262672811,0.4781500943140669,['CCNE1'],0.9992262839210598,0,0,1
211,Insulin signaling in adipocytes (diabetic condition) WP3635,0.6444985630652528,1.088479262672811,0.4781500943140669,['RPS6'],0.9992262839210598,0,0,1
212,Insulin signaling in adipocytes (normal condition) WP3634,0.6444985630652528,1.088479262672811,0.4781500943140669,['RPS6'],0.9992262839210598,0,0,1
213,Iron metabolism in placenta WP2007,0.6444985630652528,1.088479262672811,0.4781500943140669,['FTH1'],0.9992262839210598,0,0,1
214,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.6444985630652528,1.088479262672811,0.4781500943140669,['FGFR2'],0.9992262839210598,0,0,1
215,Matrix Metalloproteinases WP129,0.6444985630652528,1.088479262672811,0.4781500943140669,['MMP16'],0.9992262839210598,0,0,1
216,miR-509-3p alteration of YAP1/ECM axis WP3967,0.6444985630652528,1.088479262672811,0.4781500943140669,['COL5A1'],0.9992262839210598,0,0,1
217,"NAD metabolism, sirtuins and aging WP3630",0.6444985630652528,1.088479262672811,0.4781500943140669,['NAMPT'],0.9992262839210598,0,0,1
218,Overview of interferons-mediated signaling pathway WP4558,0.6444985630652528,1.088479262672811,0.4781500943140669,['IFNGR2'],0.9992262839210598,0,0,1
219,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.6444985630652528,1.088479262672811,0.4781500943140669,['IRF3'],0.9992262839210598,0,0,1
220,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.6444985630652528,1.088479262672811,0.4781500943140669,['ANAPC11'],0.9992262839210598,0,0,1
221,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.6444985630652528,1.088479262672811,0.4781500943140669,['IRF3'],0.9992262839210598,0,0,1
222,Transcriptional cascade regulating adipogenesis WP4211,0.6444985630652528,1.088479262672811,0.4781500943140669,['DDIT3'],0.9992262839210598,0,0,1
223,22q11.2 copy number variation syndrome WP4657,0.646900048869252,0.9162369880338554,0.3990793713686566,"['RANBP1', 'MRPL40', 'DGCR6L', 'FGFR2']",0.9992262839210598,0,0,4
224,Kit receptor signaling pathway WP304,0.6809094004375991,0.8703601108033241,0.3345020379506885,"['BAD', 'RPS6', 'KIT']",0.9992262839210598,0,0,3
225,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.6809094004375991,0.8703601108033241,0.3345020379506885,"['DLG1', 'CHP1', 'CALM2']",0.9992262839210598,0,0,3
226,3q29 copy number variation syndrome WP4906,0.6814503282058265,0.8702402957486137,0.3337649284266801,"['GRIA1', 'DLG1', 'NF2', 'WDR34']",0.9992262839210598,0,0,4
227,MAPK Signaling Pathway WP382,0.6840290036029156,0.8971286557493454,0.3406890561781628,"['PRKCG', 'DUSP4', 'MAP4K2', 'DUSP3', 'RASGRF2', 'ARRB2', 'FGF1', 'RASGRP2', 'NGF', 'STK3', 'DDIT3', 'STMN1', 'FGFR2']",0.9992262839210598,0,0,13
228,Allograft Rejection WP2328,0.6860903304915845,0.870479704797048,0.3279497319116611,"['COL5A1', 'HLA-B']",0.9992262839210598,0,0,2
229,Genes controlling nephrogenesis WP4823,0.6860903304915845,0.870479704797048,0.3279497319116611,"['ROBO2', 'FGFR2']",0.9992262839210598,0,0,2
230,Notch Signaling WP268,0.6860903304915845,0.870479704797048,0.3279497319116611,"['APH1A', 'DVL3']",0.9992262839210598,0,0,2
231,BMP Signaling Pathway in Eyelid Development WP3927,0.7109597957826466,0.8705990783410138,0.29699564443436166,['FGFR2'],0.9992262839210598,0,0,1
232,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.7109597957826466,0.8705990783410138,0.29699564443436166,['SST'],0.9992262839210598,0,0,1
233,Ebstein-Barr virus LMP1 signaling WP262,0.7109597957826466,0.8705990783410138,0.29699564443436166,['HSP90AA1'],0.9992262839210598,0,0,1
234,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.7109597957826466,0.8705990783410138,0.29699564443436166,['H3F3B'],0.9992262839210598,0,0,1
235,Genes targeted by miRNAs in adipocytes WP1992,0.7109597957826466,0.8705990783410138,0.29699564443436166,['TMSB4X'],0.9992262839210598,0,0,1
236,Overview of nanoparticle effects WP3287,0.7109597957826466,0.8705990783410138,0.29699564443436166,['BAX'],0.9992262839210598,0,0,1
237,Oxidative Stress WP408,0.7109597957826466,0.8705990783410138,0.29699564443436166,['TXN2'],0.9992262839210598,0,0,1
238,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7109597957826466,0.8705990783410138,0.29699564443436166,['LDHA'],0.9992262839210598,0,0,1
239,PPAR-alpha pathway WP2878,0.7109597957826466,0.8705990783410138,0.29699564443436166,['PPARA'],0.9992262839210598,0,0,1
240,Thiamine metabolic pathways WP4297,0.7109597957826466,0.8705990783410138,0.29699564443436166,['BCKDK'],0.9992262839210598,0,0,1
241,16p11.2 proximal deletion syndrome WP4949,0.7131827780532681,0.8364761972532555,0.2827436270615308,"['UNC13B', 'PCNA', 'TMEM219', 'SEZ6L2', 'CCT7']",0.9992262839210598,0,0,5
242,Pathways Regulating Hippo Signaling WP4540,0.7146096910670318,0.8417562724014337,0.2828459089402833,"['PRKCG', 'KIT', 'CDH11', 'NF2', 'FGFR2', 'STK3']",0.9992262839210598,0,0,6
243,Senescence and Autophagy in Cancer WP615,0.7146096910670318,0.8417562724014337,0.2828459089402833,"['GABARAPL1', 'MAP1LC3A', 'PCNA', 'IGFBP5', 'SQSTM1', 'ATG7']",0.9992262839210598,0,0,6
244,Adipogenesis WP236,0.7170460051957501,0.8455359901143034,0.2812381875551698,"['BMP3', 'CELF1', 'DDIT3', 'NAMPT', 'MIF', 'PPARA', 'ZMPSTE24']",0.9992262839210598,0,0,7
245,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.7174306454490612,0.8157894736842105,0.27090655052309864,"['WNT2B', 'DVL3', 'ROR2']",0.9992262839210598,0,0,3
246,Cardiac Progenitor Differentiation WP2406,0.7291917573466333,0.7911774572291177,0.24986850937167088,"['KIT', 'ROR2']",0.9992262839210598,0,0,2
247,Integrated Cancer Pathway WP1971,0.7291917573466333,0.7911774572291177,0.24986850937167088,"['BAD', 'BAX']",0.9992262839210598,0,0,2
248,Peptide GPCRs WP24,0.7291917573466333,0.7911774572291177,0.24986850937167088,"['MC1R', 'SSTR2']",0.9992262839210598,0,0,2
249,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.7291917573466333,0.7911774572291177,0.24986850937167088,"['IRF3', 'TRAF3']",0.9992262839210598,0,0,2
250,Splicing factor NOVA regulated synaptic proteins WP4148,0.7291917573466333,0.7911774572291177,0.24986850937167088,"['NTNG1', 'CLASP1']",0.9992262839210598,0,0,2
251,Type 2 papillary renal cell carcinoma WP4241,0.7291917573466333,0.7911774572291177,0.24986850937167088,"['COL21A1', 'ELOB']",0.9992262839210598,0,0,2
252,Unfolded protein response WP4925,0.7291917573466333,0.7911774572291177,0.24986850937167088,"['DDIT3', 'EIF2S1']",0.9992262839210598,0,0,2
253,Head and Neck Squamous Cell Carcinoma WP4674,0.7432234638220016,0.7907914636195598,0.2346741048769221,"['RPTOR', 'TRAF3', 'RPS6', 'FGFR2']",0.9992262839210598,0,0,4
254,Non-small cell lung cancer WP4255,0.7432234638220016,0.7907914636195598,0.2346741048769221,"['PRKCG', 'BAD', 'CYCS', 'BAX']",0.9992262839210598,0,0,4
255,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.7506202447824462,0.7676389115202867,0.2202013832774269,"['RPTOR', 'RPS6', 'PIM1']",0.9992262839210598,0,0,3
256,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.7621044380613514,0.8085602105535661,0.21966290662928198,"['YWHAE', 'SST', 'ATP1A3', 'SSTR2', 'NGF', 'GAPDH', 'SLC25A4', 'PPARGC1B']",0.9992262839210598,0,0,8
257,Hippo-Merlin Signaling Dysregulation WP4541,0.7626821194630202,0.7904040404040404,0.21413148370285306,"['PPP1R14A', 'KIT', 'CDH11', 'NF2', 'FGFR2', 'STK3']",0.9992262839210598,0,0,6
258,Alanine and aspartate metabolism WP106,0.7650053029809504,0.7253456221198157,0.19430015472017428,['GOT1'],0.9992262839210598,0,0,1
259,Cell Differentiation - Index expanded WP2023,0.7650053029809504,0.7253456221198157,0.19430015472017428,['LEFTY1'],0.9992262839210598,0,0,1
260,Differentiation of white and brown adipocyte WP2895,0.7650053029809504,0.7253456221198157,0.19430015472017428,['PPARGC1B'],0.9992262839210598,0,0,1
261,Glycerolipids and Glycerophospholipids WP4722,0.7650053029809504,0.7253456221198157,0.19430015472017428,['ETNK1'],0.9992262839210598,0,0,1
262,Kynurenine Pathway and links to Cellular Senescence WP5044,0.7650053029809504,0.7253456221198157,0.19430015472017428,['EIF2AK1'],0.9992262839210598,0,0,1
263,miRNAs involved in DNA damage response WP1545,0.7650053029809504,0.7253456221198157,0.19430015472017428,['CCNE1'],0.9992262839210598,0,0,1
264,miRNAs involvement in the immune response in sepsis WP4329,0.7650053029809504,0.7253456221198157,0.19430015472017428,['TRAF3'],0.9992262839210598,0,0,1
265,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.7650053029809504,0.7253456221198157,0.19430015472017428,['PPARA'],0.9992262839210598,0,0,1
266,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.7650053029809504,0.7253456221198157,0.19430015472017428,['BAX'],0.9992262839210598,0,0,1
267,Signal Transduction of S1P Receptor WP26,0.7650053029809504,0.7253456221198157,0.19430015472017428,['ASAH1'],0.9992262839210598,0,0,1
268,Small cell lung cancer WP4658,0.7652125951389291,0.7763975155279503,0.20776520312178412,"['TRAF3', 'CCNE1', 'COL4A4', 'CYCS', 'BAX']",0.9992262839210598,0,0,5
269,Aryl Hydrocarbon Receptor Pathway WP2873,0.7671596642331329,0.7250922509225092,0.19219319282594668,"['HSP90AA1', 'BAX']",0.9992262839210598,0,0,2
270,Monoamine GPCRs WP58,0.7671596642331329,0.7250922509225092,0.19219319282594668,"['HTR2C', 'HTR5A']",0.9992262839210598,0,0,2
271,Nuclear receptors WP170,0.7671596642331329,0.7250922509225092,0.19219319282594668,"['NR2F2', 'PPARA']",0.9992262839210598,0,0,2
272,Exercise-induced Circadian Regulation WP410,0.7806045516482414,0.7248384118190212,0.17953275691028472,"['DAZAP2', 'SUMO1', 'GSTP1']",0.9992262839210598,0,0,3
273,Corticotropin-releasing hormone signaling pathway WP2355,0.7954293167923325,0.7245841035120147,0.1658379469020492,"['HSP90AA1', 'TRIM28', 'CRH', 'ARRB2']",0.9992262839210598,0,0,4
274,Wnt signaling WP428,0.7954293167923325,0.7245841035120147,0.1658379469020492,"['PRKCG', 'WNT2B', 'DVL3', 'ROR2']",0.9992262839210598,0,0,4
275,Genotoxicity pathway WP4286,0.8004062472196294,0.669173999432302,0.14898213633531318,"['RPS27', 'PHLDA3']",0.9992262839210598,0,0,2
276,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8004062472196294,0.669173999432302,0.14898213633531318,"['PRKCG', 'ARRB2']",0.9992262839210598,0,0,2
277,Prader-Willi and Angelman Syndrome WP3998,0.8004062472196294,0.669173999432302,0.14898213633531318,"['HTR2C', 'NGF']",0.9992262839210598,0,0,2
278,Vitamin D Receptor Pathway WP2877,0.8044976231310866,0.7449206349206349,0.16204799906842657,"['IGFBP5', 'BCL6', 'CCNE1', 'S100A6', 'CLEC16A', 'CLPTM1L']",0.9992262839210598,0,0,6
279,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.8075494761800596,0.6865432278757836,0.14674927057364956,"['BAD', 'CYCS', 'BAX']",0.9992262839210598,0,0,3
280,DNA damage response WP707,0.8075494761800596,0.6865432278757836,0.14674927057364956,"['CCNE1', 'CYCS', 'BAX']",0.9992262839210598,0,0,3
281,Wnt signaling pathway and pluripotency WP399,0.8075494761800596,0.6865432278757836,0.14674927057364956,"['PRKCG', 'WNT2B', 'DVL3']",0.9992262839210598,0,0,3
282,Constitutive Androstane Receptor Pathway WP2875,0.8089527434377198,0.6215931533903885,0.13178693391279572,['HSP90AA1'],0.9992262839210598,0,0,1
283,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.8089527434377198,0.6215931533903885,0.13178693391279572,['RPS6'],0.9992262839210598,0,0,1
284,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8089527434377198,0.6215931533903885,0.13178693391279572,['STK3'],0.9992262839210598,0,0,1
285,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8089527434377198,0.6215931533903885,0.13178693391279572,['GSTP1'],0.9992262839210598,0,0,1
286,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8089527434377198,0.6215931533903885,0.13178693391279572,['BAX'],0.9992262839210598,0,0,1
287,Sleep regulation WP3591,0.8089527434377198,0.6215931533903885,0.13178693391279572,['CRH'],0.9992262839210598,0,0,1
288,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.8089527434377198,0.6215931533903885,0.13178693391279572,['PPARA'],0.9992262839210598,0,0,1
289,Statin inhibition of cholesterol production WP430,0.8089527434377198,0.6215931533903885,0.13178693391279572,['APOE'],0.9992262839210598,0,0,1
290,Striated Muscle Contraction Pathway WP383,0.8089527434377198,0.6215931533903885,0.13178693391279572,['DMD'],0.9992262839210598,0,0,1
291,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8089527434377198,0.6215931533903885,0.13178693391279572,['CALM2'],0.9992262839210598,0,0,1
292,Vitamin B12 metabolism WP1533,0.8089527434377198,0.6215931533903885,0.13178693391279572,['APOE'],0.9992262839210598,0,0,1
293,DNA damage response (only ATM dependent) WP710,0.8097580963209474,0.7243293246993524,0.15284777305085834,"['WNT2B', 'BCL6', 'BAD', 'DVL3', 'BAX']",0.9992262839210598,0,0,5
294,Ras signaling WP4223,0.8147539370302609,0.7663444207766672,0.15700031406128617,"['PRKCG', 'RASA4', 'BAD', 'RASGRF2', 'KIT', 'KSR2', 'RASGRP2', 'CALM2', 'FGFR2']",0.9992262839210598,0,0,9
295,Melanoma WP4685,0.8181380774845606,0.6954528650646951,0.13959419059037118,"['BAD', 'KIT', 'BAX', 'CALM2']",0.9992262839210598,0,0,4
296,Disruption of postsynaptic signaling by CNV WP4875,0.829368922726066,0.6212440695835529,0.1162286781323667,"['DLG1', 'FMR1']",0.9992262839210598,0,0,2
297,G13 Signaling Pathway WP524,0.829368922726066,0.6212440695835529,0.1162286781323667,"['ARHGDIG', 'CALM2']",0.9992262839210598,0,0,2
298,miRNA regulation of DNA damage response WP1530,0.831646847213402,0.6520775623268698,0.1202087971845264,"['CCNE1', 'CYCS', 'BAX']",0.9992262839210598,0,0,3
299,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.831646847213402,0.6520775623268698,0.1202087971845264,"['PCNA', 'COL4A4', 'TLN1']",0.9992262839210598,0,0,3
300,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8355100633084517,0.7238183503243745,0.13007948494087881,"['GRIA1', 'DLG1', 'BAD', 'RPS6', 'NGF', 'SQSTM1', 'EIF2S1']",0.9992262839210598,0,0,7
301,ESC Pluripotency Pathways WP3931,0.838729653044201,0.6685624911133229,0.11757797911035042,"['WNT2B', 'DVL3', 'FGF1', 'FGFR2']",0.9992262839210598,0,0,4
302,Angiogenesis WP1539,0.8446874607652686,0.543778801843318,0.09178365666959315,['FGFR2'],0.9992262839210598,0,0,1
303,IL-7 signaling pathway WP205,0.8446874607652686,0.543778801843318,0.09178365666959315,['BAD'],0.9992262839210598,0,0,1
304,Nanoparticle-mediated activation of receptor signaling WP2643,0.8446874607652686,0.543778801843318,0.09178365666959315,['TLN1'],0.9992262839210598,0,0,1
305,Physiological and pathological hypertrophy of the heart WP1528,0.8446874607652686,0.543778801843318,0.09178365666959315,['CALM2'],0.9992262839210598,0,0,1
306,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.8446874607652686,0.543778801843318,0.09178365666959315,['HTR2C'],0.9992262839210598,0,0,1
307,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8446874607652686,0.543778801843318,0.09178365666959315,['RPS6'],0.9992262839210598,0,0,1
308,Trans-sulfuration and one-carbon metabolism WP2525,0.8446874607652686,0.543778801843318,0.09178365666959315,['GSS'],0.9992262839210598,0,0,1
309,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.8531034493166193,0.6208943411159478,0.09864425428080677,"['WNT2B', 'DVL3', 'ROR2']",0.9992262839210598,0,0,3
310,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.8531034493166193,0.6208943411159478,0.09864425428080677,"['CCNE1', 'APEX1', 'RPS6']",0.9992262839210598,0,0,3
311,IL-6 signaling pathway WP364,0.8544865492502774,0.5797047970479705,0.09116119822566948,"['BAD', 'VIP']",0.9992262839210598,0,0,2
312,Osteoblast differentiation WP4787,0.8573291532462772,0.6436639967139043,0.09908136043102982,"['PRKCG', 'WNT2B', 'FGF1', 'FGFR2']",0.9992262839210598,0,0,4
313,Spinal Cord Injury WP2431,0.8573291532462772,0.6436639967139043,0.09908136043102982,"['APEX1', 'OMG', 'MBP', 'MIF']",0.9992262839210598,0,0,4
314,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8616148440566274,0.7650354259350799,0.11394967406403475,"['PFKFB2', 'HSP90AA1', 'BAD', 'RPS6', 'VEGFB', 'FGF1', 'NGF', 'RPTOR', 'EFNA3', 'COL5A1', 'PIK3IP1', 'COL4A4', 'PDGFC', 'KIT', 'FGFR2']",0.9992262839210598,0,0,15
315,"GPCRs, Class A Rhodopsin-like WP455",0.8636366151210437,0.6580607181902279,0.0964737958933811,"['MC1R', 'HTR2C', 'SSTR2', 'HTR5A', 'MCHR1']",0.9992262839210598,0,0,5
316,Integrated breast cancer pathway WP1984,0.8648927887971724,0.6906226303816665,0.10024368371772704,"['FER', 'BAD', 'DCAKD', 'ODC1', 'BAX', 'FAU', 'DHTKD1']",0.9992262839210598,0,0,7
317,7-oxo-C and 7beta-HC pathways WP5064,0.87374306291208,0.48325652841781874,0.06522461409541007,['EPHX2'],0.9992262839210598,0,0,1
318,Canonical and non-canonical Notch signaling WP3845,0.87374306291208,0.48325652841781874,0.06522461409541007,['MFAP1'],0.9992262839210598,0,0,1
319,Endothelin Pathways WP2197,0.87374306291208,0.48325652841781874,0.06522461409541007,['CALM2'],0.9992262839210598,0,0,1
320,FOXA2 pathway WP5066,0.87374306291208,0.48325652841781874,0.06522461409541007,['PPARGC1B'],0.9992262839210598,0,0,1
321,miRNA targets in ECM and membrane receptors WP2911,0.87374306291208,0.48325652841781874,0.06522461409541007,['COL5A1'],0.9992262839210598,0,0,1
322,Sphingolipid Metabolism (general overview) WP4725,0.87374306291208,0.48325652841781874,0.06522461409541007,['ASAH1'],0.9992262839210598,0,0,1
323,Sphingolipid Metabolism (integrated pathway) WP4726,0.87374306291208,0.48325652841781874,0.06522461409541007,['ASAH1'],0.9992262839210598,0,0,1
324,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.87374306291208,0.48325652841781874,0.06522461409541007,['TRAF3'],0.9992262839210598,0,0,1
325,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.87374306291208,0.48325652841781874,0.06522461409541007,['PPIB'],0.9992262839210598,0,0,1
326,ATM Signaling Network in Development and Disease  WP3878,0.8761836387349551,0.5433579335793358,0.07182082168788223,"['DCLRE1C', 'TRIM28']",0.9992262839210598,0,0,2
327,Interferon type I signaling pathways WP585,0.8761836387349551,0.5433579335793358,0.07182082168788223,"['RPTOR', 'RPS6']",0.9992262839210598,0,0,2
328,Nephrotic syndrome WP4758,0.8761836387349551,0.5433579335793358,0.07182082168788223,"['COL4A4', 'ZMPSTE24']",0.9992262839210598,0,0,2
329,Hepatitis B infection WP4666,0.8778884047851644,0.6751312944084028,0.08792626088132992,"['PRKCG', 'PCNA', 'IRF3', 'TRAF3', 'BAD', 'CYCS', 'BAX']",0.9992262839210598,0,0,7
330,Myometrial relaxation and contraction pathways WP289,0.8917894553949967,0.6847969505937546,0.07842651513278956,"['PRKCG', 'YWHAE', 'IGFBP5', 'GRK4', 'GSTO1', 'RGS16', 'CRH', 'ARRB2', 'CALM2']",0.9992262839210598,0,0,9
331,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.8948604075462345,0.5112871716952464,0.05679763520773097,"['GRIA1', 'TMSB4X']",0.9992262839210598,0,0,2
332,Glucocorticoid Receptor Pathway WP2880,0.8948604075462345,0.5112871716952464,0.05679763520773097,"['HSP90AA1', 'SERPINB9']",0.9992262839210598,0,0,2
333,Notch Signaling Pathway Netpath WP61,0.8948604075462345,0.5112871716952464,0.05679763520773097,"['APH1A', 'SAP30']",0.9992262839210598,0,0,2
334,PPAR signaling pathway WP3942,0.8948604075462345,0.5112871716952464,0.05679763520773097,"['PPARA', 'CPT1B']",0.9992262839210598,0,0,2
335,RANKL/RANK signaling pathway WP2018,0.8948604075462345,0.5112871716952464,0.05679763520773097,"['TRAF3', 'SQSTM1']",0.9992262839210598,0,0,2
336,Rett syndrome causing genes WP4312,0.8948604075462345,0.5112871716952464,0.05679763520773097,"['IMPDH2', 'GPS2']",0.9992262839210598,0,0,2
337,EGF/EGFR signaling pathway WP437,0.8960560207669193,0.6350948509485095,0.06970314905205585,"['NDUFA13', 'PCNA', 'STMN1', 'AP2S1', 'NEDD8', 'AP2M1']",0.9992262839210598,0,0,6
338,BDNF-TrkB Signaling WP3676,0.8973669937601686,0.43483870967741933,0.04708884300861636,['TRPC3'],0.9992262839210598,0,0,1
339,IL17 signaling pathway WP2112,0.8973669937601686,0.43483870967741933,0.04708884300861636,['TRAF3'],0.9992262839210598,0,0,1
340,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8973669937601686,0.43483870967741933,0.04708884300861636,['NELFE'],0.9992262839210598,0,0,1
341,Netrin-UNC5B signaling pathway WP4747,0.8973669937601686,0.43483870967741933,0.04708884300861636,['DAPK1'],0.9992262839210598,0,0,1
342,Thermogenesis WP4321,0.9025080349207905,0.5789279112754159,0.05938508541573687,"['RPTOR', 'RPS6', 'ZNF516', 'CPT1B']",0.9992262839210598,0,0,4
343,ErbB signaling pathway WP673,0.9037536155656629,0.5429362880886427,0.054944340605780344,"['PRKCG', 'BTC', 'BAD']",0.9992262839210598,0,0,3
344,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9037536155656629,0.5429362880886427,0.054944340605780344,"['EIF2B5', 'CALM2', 'FGFR2']",0.9992262839210598,0,0,3
345,Nuclear Receptors Meta-Pathway WP2882,0.9082824738389708,0.7039142590866729,0.06771644911061733,"['HSP90AA1', 'GSTP1', 'SLC39A11', 'SERPINB9', 'PSMC5', 'FTH1', 'BLVRB', 'BAX', 'SLC39A7', 'PPARA', 'SQSTM1', 'CES2', 'FTL']",0.9992262839210598,0,0,13
346,Cardiac Hypertrophic Response WP2795,0.9108870389365686,0.482779827798278,0.045060924450653315,"['CALM2', 'FGFR2']",0.9992262839210598,0,0,2
347,"GPCRs, Other WP117",0.9108870389365686,0.482779827798278,0.045060924450653315,"['SSTR2', 'CELSR2']",0.9992262839210598,0,0,2
348,MET in type 1 papillary renal cell carcinoma WP4205,0.9108870389365686,0.482779827798278,0.045060924450653315,"['BAD', 'RPL11']",0.9992262839210598,0,0,2
349,Phosphodiesterases in neuronal function WP4222,0.9108870389365686,0.482779827798278,0.045060924450653315,"['GRIA1', 'PDE3A']",0.9992262839210598,0,0,2
350,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9165738897249663,0.39522413070800166,0.034428998968995074,['IRF3'],0.9992262839210598,0,0,1
351,Lung fibrosis WP3624,0.9165738897249663,0.39522413070800166,0.034428998968995074,['FGF1'],0.9992262839210598,0,0,1
352,miRNA regulation of prostate cancer signaling pathways WP3981,0.9165738897249663,0.39522413070800166,0.034428998968995074,['BAD'],0.9992262839210598,0,0,1
353,Pre-implantation embryo WP3527,0.9165738897249663,0.39522413070800166,0.034428998968995074,['DDIT3'],0.9992262839210598,0,0,1
354,Tumor suppressor activity of SMARCB1 WP4204,0.9165738897249663,0.39522413070800166,0.034428998968995074,['H3F3B'],0.9992262839210598,0,0,1
355,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9167524884035652,0.5211080332409972,0.04529354174743865,"['ENPP1', 'SLC38A2', 'CALM2']",0.9992262839210598,0,0,3
356,Endochondral Ossification WP474,0.9167524884035652,0.5211080332409972,0.04529354174743865,"['ENPP1', 'SLC38A2', 'CALM2']",0.9992262839210598,0,0,3
357,Calcium Regulation in the Cardiac Cell WP536,0.9231862201154263,0.6305279136447968,0.050394508154996166,"['PRKCG', 'YWHAE', 'SLC8A3', 'GRK4', 'RGS16', 'ATP1B2', 'ARRB2', 'CALM2']",0.9992262839210598,0,0,8
358,Breast cancer pathway WP4262,0.9248324943485609,0.5708651833098008,0.044608915395759986,"['WNT2B', 'KIT', 'DVL3', 'BAX', 'FGF1']",0.9992262839210598,0,0,5
359,AMP-activated protein kinase (AMPK) signaling WP1403,0.9281310317484222,0.5009588749200937,0.037362694232055425,"['RPTOR', 'CPT1B', 'PPARGC1B']",0.9992262839210598,0,0,3
360,PI3K-Akt signaling pathway WP4172,0.929083186493194,0.6780336630772859,0.049874122189544644,"['HSP90AA1', 'BAD', 'RPS6', 'VEGFB', 'FGF1', 'NGF', 'RPTOR', 'EFNA3', 'CCNE1', 'COL4A4', 'PDGFC', 'KIT', 'FGFR2']",0.9992262839210598,0,0,13
361,Bladder cancer WP2828,0.9321889955672799,0.3622119815668203,0.02543441664986322,['DAPK1'],0.9992262839210598,0,0,1
362,Folate Metabolism WP176,0.9321889955672799,0.3622119815668203,0.02543441664986322,['GPX4'],0.9992262839210598,0,0,1
363,IL-2 signaling pathway WP49,0.9321889955672799,0.3622119815668203,0.02543441664986322,['RPS6'],0.9992262839210598,0,0,1
364,Intraflagellar transport proteins binding to dynein WP4532,0.9321889955672799,0.3622119815668203,0.02543441664986322,['WDR34'],0.9992262839210598,0,0,1
365,MAPK Cascade WP422,0.9321889955672799,0.3622119815668203,0.02543441664986322,['MBP'],0.9992262839210598,0,0,1
366,Neovascularisation processes WP4331,0.9321889955672799,0.3622119815668203,0.02543441664986322,['KIT'],0.9992262839210598,0,0,1
367,Oxysterols derived from cholesterol WP4545,0.9321889955672799,0.3622119815668203,0.02543441664986322,['EPHX2'],0.9992262839210598,0,0,1
368,Sphingolipid pathway WP1422,0.9321889955672799,0.3622119815668203,0.02543441664986322,['ASAH1'],0.9992262839210598,0,0,1
369,The influence of laminopathies on Wnt signaling WP4844,0.9321889955672799,0.3622119815668203,0.02543441664986322,['ZMPSTE24'],0.9992262839210598,0,0,1
370,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9363060260570659,0.43431734317343174,0.028583686057278623,"['PRKCG', 'IFI27L2']",0.9992262839210598,0,0,2
371,DNA IR-damage and cellular response via ATR WP4016,0.9380644763224129,0.48230224684518314,0.03083676306465636,"['PCNA', 'TRIM28', 'BCL6']",0.9992262839210598,0,0,3
372,Glioblastoma signaling pathways WP2261,0.9380644763224129,0.48230224684518314,0.03083676306465636,"['PRKCG', 'CCNE1', 'FGFR2']",0.9992262839210598,0,0,3
373,Leptin signaling pathway WP2034,0.9380644763224129,0.48230224684518314,0.03083676306465636,"['BAD', 'RPS6', 'BAX']",0.9992262839210598,0,0,3
374,Interleukin-11 Signaling Pathway WP2332,0.9448834894813407,0.3342786246012052,0.018951475560750317,['RPS6'],0.9992262839210598,0,0,1
375,Vitamin D-sensitive calcium signaling in depression WP4698,0.9448834894813407,0.3342786246012052,0.018951475560750317,['GPX4'],0.9992262839210598,0,0,1
376,Prolactin Signaling Pathway WP2037,0.9462735160985984,0.41354770690564047,0.02283760251464411,"['RPS6', 'PPIB']",0.9992262839210598,0,0,2
377,G1 to S cell cycle control WP45,0.9547434724290903,0.3946662193894666,0.018278014743252396,"['PCNA', 'CCNE1']",0.9992262839210598,0,0,2
378,Toll-like Receptor Signaling Pathway WP75,0.9547434724290903,0.3946662193894666,0.018278014743252396,"['IRF3', 'TRAF3']",0.9992262839210598,0,0,2
379,Regulation of Actin Cytoskeleton WP51,0.9547674664006586,0.516056561384961,0.02388694683906496,"['TMSB4X', 'BRK1', 'FGF1', 'WASF1', 'FGFR2']",0.9992262839210598,0,0,5
380,Aryl Hydrocarbon Receptor Netpath WP2586,0.9552032246399957,0.31033574720210666,0.014223047429629737,['HSP90AA1'],0.9992262839210598,0,0,1
381,ATM Signaling Pathway WP2516,0.9552032246399957,0.31033574720210666,0.014223047429629737,['CCNE1'],0.9992262839210598,0,0,1
382,IL-5 signaling pathway WP127,0.9552032246399957,0.31033574720210666,0.014223047429629737,['RPS6'],0.9992262839210598,0,0,1
383,Target Of Rapamycin (TOR) Signaling WP1471,0.9552032246399957,0.31033574720210666,0.014223047429629737,['RPTOR'],0.9992262839210598,0,0,1
384,Mesodermal commitment pathway WP2857,0.9567305620401714,0.4818237831176833,0.021312738596807754,"['LEFTY1', 'TRIM28', 'RPL38', 'ACVR2A']",0.9992262839210598,0,0,4
385,Cell cycle WP179,0.9624233043168389,0.4687016036369086,0.017951693167206493,"['YWHAE', 'PCNA', 'CCNE1', 'ANAPC11']",0.9992262839210598,0,0,4
386,IL-3 signaling pathway WP286,0.9635921123411793,0.2895852534562212,0.010739904442655528,['BAD'],0.9992262839210598,0,0,1
387,Pathogenic Escherichia coli infection WP2272,0.9635921123411793,0.2895852534562212,0.010739904442655528,['ARPC3'],0.9992262839210598,0,0,1
388,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.9635921123411793,0.2895852534562212,0.010739904442655528,['CALM2'],0.9992262839210598,0,0,1
389,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9635921123411793,0.2895852534562212,0.010739904442655528,['RPTOR'],0.9992262839210598,0,0,1
390,TGF-beta Receptor Signaling WP560,0.9635921123411793,0.2895852534562212,0.010739904442655528,['LEFTY1'],0.9992262839210598,0,0,1
391,Gastrin signaling pathway WP4659,0.967414277579752,0.45627006518143787,0.015115524598240728,"['BAD', 'RPS6', 'KIT', 'ARRB2']",0.9992262839210598,0,0,4
392,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9704111465964322,0.2714285714285714,0.00815247516501634,['BANF1'],0.9992262839210598,0,0,1
393,p38 MAPK Signaling Pathway WP400,0.9704111465964322,0.2714285714285714,0.00815247516501634,['DDIT3'],0.9992262839210598,0,0,1
394,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9704111465964322,0.2714285714285714,0.00815247516501634,['ZMPSTE24'],0.9992262839210598,0,0,1
395,Androgen receptor signaling pathway WP138,0.9712460462048884,0.40650969529085873,0.011860102533399568,"['SUMO1', 'CCNE1', 'PARK7']",0.9992262839210598,0,0,3
396,G Protein Signaling Pathways WP35,0.9712460462048884,0.40650969529085873,0.011860102533399568,"['PRKCG', 'AKAP5', 'CALM2']",0.9992262839210598,0,0,3
397,Joubert Syndrome WP4656,0.9731490063801786,0.3470848708487085,0.009446979383524493,"['CEP120', 'DVL3']",0.9992262839210598,0,0,2
398,p53 transcriptional gene network WP4963,0.9759538800457073,0.2554079696394687,0.006216616632658862,['BAX'],0.9992262839210598,0,0,1
399,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9759538800457073,0.2554079696394687,0.006216616632658862,['LEFTY1'],0.9992262839210598,0,0,1
400,Circadian rhythm related genes WP3594,0.9785021237865291,0.4808641975308642,0.010450295433373476,"['PRKCG', 'NAMPT', 'CRH', 'PPARA', 'RPS27A', 'UBA52']",0.9992262839210598,0,0,6
401,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9804590140764582,0.2411674347158218,0.004759303128020792,['MBP'],0.9992262839210598,0,0,1
402,IL-4 signaling pathway WP395,0.9841206404287917,0.2284259034683483,0.003656364869615409,['BAD'],0.9992262839210598,0,0,1
403,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9848051591492316,0.3610341643582641,0.005527962096635995,"['RPTOR', 'MAP4K2', 'SESN3']",0.9992262839210598,0,0,3
404,Pancreatic adenocarcinoma pathway WP4263,0.9868066690926472,0.2989566102557577,0.003970483413116874,"['BAD', 'BAX']",0.9992262839210598,0,0,2
405,IL-1 signaling pathway WP195,0.9870965714877193,0.21695852534562213,0.002817727343520254,['SQSTM1'],0.9992262839210598,0,0,1
406,Focal Adhesion WP306,0.9873459783470683,0.44731800766283525,0.005696490005658789,"['PRKCG', 'BAD', 'COL4A4', 'PDGFC', 'VEGFB', 'TLN1']",0.9992262839210598,0,0,6
407,B Cell Receptor Signaling Pathway WP23,0.9889784265781982,0.28892988929889296,0.0032021408990900117,"['BCL6', 'CD81']",0.9992262839210598,0,0,2
408,Integrin-mediated Cell Adhesion WP185,0.9907999432903299,0.2795500535650518,0.0025837801166007403,"['GIT2', 'TLN1']",0.9992262839210598,0,0,2
409,Endoderm differentiation WP2853,0.9921088262397462,0.32465373961218835,0.0025720607602986324,"['DUSP4', 'TCEAL2', 'NME1']",0.9992262839210598,0,0,3
410,Insulin Signaling WP481,0.9926822449807504,0.36044362292051757,0.002647336266973071,"['MAP4K2', 'RAB4A', 'ENPP1', 'STX4']",0.9992262839210598,0,0,4
411,AGE/RAGE pathway WP2324,0.9930778114333797,0.18853937086756162,0.0013096431233649362,['CYCS'],0.9992262839210598,0,0,1
412,Oncostatin M Signaling Pathway WP2374,0.9930778114333797,0.18853937086756162,0.0013096431233649362,['RPS6'],0.9992262839210598,0,0,1
413,Genes related to primary cilium development (based on CRISPR) WP4536,0.994672125799035,0.2547210766225309,0.0013607500325611994,"['CEP120', 'WDR34']",0.9992262839210598,0,0,2
414,Chemokine signaling pathway WP3929,0.9952191867085894,0.30181021709721056,0.0014463584436748016,"['GRK4', 'ARRB2', 'RASGRP2']",0.9992262839210598,0,0,3
415,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.99543035350872,0.1733824884792627,0.0007941124717965106,['DMD'],0.9992262839210598,0,0,1
416,T-cell receptor (TCR) signaling pathway WP69,0.99543035350872,0.1733824884792627,0.0007941124717965106,['RIPK2'],0.9992262839210598,0,0,1
417,TGF-beta Signaling Pathway WP366,0.995564904722769,0.24739061676331048,0.0010996412694487389,"['PARD6A', 'SUMO1']",0.9992262839210598,0,0,2
418,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9982420514640088,0.21623616236162363,0.0003804665634395739,"['WNT2B', 'COL4A4']",0.9992262839210598,0,0,2
419,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9989318854604005,0.13525345622119817,0.00014454339131931686,['PPARGC1B'],0.9992262839210598,0,0,1
420,Ciliopathies WP4803,0.9992262839210598,0.2782183531095343,0.00021534533207703347,"['CEP120', 'KIF7', 'WDR34', 'SPATA7']",0.9992262839210598,0,0,4
